Kawasaki City becomes first dekokatsu subsidy municipality for promoting decarbonization lifestyle promotion project 2025-09-11
Eisai Presents Clinical Study Results of Novel Orexin Receptor Agonist E2086 for Narcolepsy at World Sleep 2025 2025-09-08
Fujitsu develops generative AI reconstruction technology for optimized and energy-efficient AI models based on Takane LLM 2025-09-08
Mitsubishi Power Receives Contract for Large-Scale GTCC Project with 2,800 MW Total Output for Taiwan’s Tung Hsiao Power Plant 2025-09-05
Hitachi announces historic $1 billion USD manufacturing investment to power America’s energy future through production of critical grid infrastructure 2025-09-05
NEC participates in Locked Shields 2025 hosted by the NATO Cooperative Cyber Defence Centre of Excellence 2025-09-05
Signing of Agreement with Yamaguchi Prefecture and Iwakuni City to Construct Module Pack Plant of Automotive Cylindrical Lithium-Ion Batteries 2025-09-04
Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025 2025-09-04
Honda Premieres a New Color Option for Four Large-size Outboard Motors at HISWA In-Water Boat Show 2025 in the Netherlands 2025-09-03
Mitsubishi Corporation Invests in Commonwealth Fusion Systems, a US Fusion Energy Start-up from MIT 2025-09-02
Hitachi has been certified as a Gold Partner of Scaled Agile, Inc., the provider of the large-scale agile framework “SAFe(R)” 2025-09-02
Honda to Provide Official Vehicles for World Athletics Championships Tokyo 25 as Official Global Partner 2025-09-02
TANAKA Memorial Foundation to Offer Precious Metals Research Grants of Up to 10 Million Yen (from a Grant Pool of 20 Million Yen) – Applications for Research Projects Open on September 1 2025-09-02
FDA Approves LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) Subcutaneous Injection for Maintenance Dosing for the Treatment of Early Alzheimer’s Disease 2025-09-02
Honda Announces New Plan for Relocation of Global Head Office to Yaesu Area in Tokyo and Reconstruction of Honda Aoyama Building 2025-09-02
Ministry Of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anticancer Agent Tazemetostat for Unresectable INI1-Negative Epithelioid Sarcoma 2025-09-02
